STOCK TITAN

The Buxton Helmsley Group Calls on U.S. Securities and Exchange Commission to Intervene in Mallinckrodt Plc. Fraud Involving False Statements of Financials, Insider Trading on Undisclosed Information, and Electoral Tampering

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

NEW YORK--(BUSINESS WIRE)-- The Buxton Helmsley Group, Inc. (together with certain of its affiliates and clients, “BHG” or “we”), the New York City-based investment advisor to clients with significant holdings of Mallinckrodt Plc. (“Mallinckrodt” or the “Company”) (OTC: MNKKQ) common stock, and with the backing of other various shareholders, has issued an open letter to the U.S. Securities and Exchange Commission (the “Commission”), its Chairman and Commissioners, for immediate intervention in fraudulent statements of financials, bankruptcy fraud, insider trading on undisclosed information, proxy fraud, and electoral fraud, at the Company.

The full open letter to the Commission may be found at: http://www.revivemallinckrodt.com/

Members of the Mallinckrodt Plc. Board of Directors: Mark C. Trudeau, Angus Russell, Anne C. Whitaker, Joann A. Reed, Carlos V. Paya (M.D., Ph.D.), J. Martin Carroll, Paul R. Carter, David Norton, Kneeland Youngblood, and David Carlucci.

About Buxton Helmsley: The Buxton Helmsley Group, Inc. ("BHG") is a premier financial service, asset management and securities research firm, providing an array of services to a diversified group of individuals, corporations, trusts and other entities. The firm is headquartered in New York City.

Media:

Public Relations and Corp. Comm.

The Buxton Helmsley Group, Inc.

Tel: +1 (212) 561 - 5540, Option 4

press@buxtonhelmsley.com

 

Source: The Buxton Helmsley Group, Inc.

MNKKQ

OTC:MNKKQ

MNKKQ Rankings

MNKKQ Latest News

MNKKQ Stock Data

1.70M
78.68M
11.19%
0.41%
49.32%
Drug Manufacturers—Specialty & Generic
Healthcare
Link
Ireland
Dublin